Elevance Health, Inc. (ELV) is currently trading at $396.09. Based on 21 Wall Street analysts, the average target price is $451.38, implying a 14.0% upside. The consensus recommendation is BUY.
No firm-level price target raises or cuts for ELV are recorded in the past 30 days. Over the past 90 days, the feed records 10 target raises and 3 target cuts for ELV.
Elevance Health, Inc.
Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).
Price (USD)
Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price
| Firm | Date | PT action | Prior → Current |
|---|---|---|---|
| Bernstein | Jul 17, 2026 | Raises | $482.00 → $488.00 |
| Leerink Partners | Jul 17, 2026 | Raises | $364.00 → $395.00 |
| RBC Capital | Jul 16, 2026 | Lowers | $439.00 → $424.00 |
| Wells Fargo | Jul 16, 2026 | Lowers | $492.00 → $473.00 |
| Guggenheim | Jul 16, 2026 | Raises | $399.00 → $455.00 |
| Barclays | Jul 16, 2026 | Lowers | $480.00 → $457.00 |
| Baird | Jul 16, 2026 | Raises | $331.00 → $393.00 |
| TD Cowen | Jul 14, 2026 | Raises | $400.00 → $465.00 |
| Truist Securities | Jul 14, 2026 | Raises | $450.00 → $475.00 |
| Wells Fargo | Jul 13, 2026 | Raises | $391.00 → $492.00 |
| RBC Capital | Jul 9, 2026 | Raises | $358.00 → $439.00 |
| Cantor Fitzgerald | Jul 7, 2026 | Raises | $400.00 → $450.00 |
| Bernstein | Jul 2, 2026 | Raises | $424.00 → $482.00 |
| Mizuho | Jun 8, 2026 | Raises | $435.00 → $465.00 |
| JP Morgan | Jun 8, 2026 | Raises | $411.00 → $476.00 |
| B of A Securities | Jun 4, 2026 | Raises | $435.00 → $460.00 |
| Morgan Stanley | Jun 4, 2026 | Raises | $352.00 → $404.00 |
| Truist Securities | Jun 1, 2026 | Raises | $375.00 → $450.00 |
| Barclays | May 26, 2026 | Raises | $408.00 → $480.00 |
| UBS | May 22, 2026 | Raises | $400.00 → $460.00 |
PT action: Raises
$482.00 → $488.00
PT action: Raises
$364.00 → $395.00
PT action: Lowers
$439.00 → $424.00
PT action: Lowers
$492.00 → $473.00
PT action: Raises
$399.00 → $455.00
PT action: Lowers
$480.00 → $457.00
PT action: Raises
$331.00 → $393.00
PT action: Raises
$400.00 → $465.00
PT action: Raises
$450.00 → $475.00
PT action: Raises
$391.00 → $492.00
PT action: Raises
$358.00 → $439.00
PT action: Raises
$400.00 → $450.00
PT action: Raises
$424.00 → $482.00
PT action: Raises
$435.00 → $465.00
PT action: Raises
$411.00 → $476.00
PT action: Raises
$435.00 → $460.00
PT action: Raises
$352.00 → $404.00
PT action: Raises
$375.00 → $450.00
PT action: Raises
$408.00 → $480.00
PT action: Raises
$400.00 → $460.00
Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.
$451.38
Based on 21 analysts
+13.96%
$85.90B
Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.
Major insider buying detected recently.
PERU RAMIRO G (Director) - 1,000 shares
| Date | Name | Position | Transaction | Shares |
|---|---|---|---|---|
| 7/17/2026 | PERU RAMIRO G | Director | Purchase at price 366.05 per share. | 1,000 |
| 7/17/2026 | BOUDREAUX GAIL A KOZIARA | Chief Executive Officer | Purchase at price 366.41 - 368.25 per share. | 2,725 |
| 6/12/2026 | PENCZEK RONALD W | Officer | Sale at price 403.16 per share. | 369 |
| 6/11/2026 | DIXON ROBERT L JR | Director | Sale at price 401.77 per share. | 151 |
| 5/19/2026 | PENCZEK RONALD W | Officer | Sale at price 403.13 per share. | 1,531 |
| 3/12/2026 | SCHULMAN AMY W. | Director | Sale at price 287.50 per share. | 26 |
| 3/6/2026 | KENDRICK CHARLES MORGAN JR | Officer | Sale at price 284.92 per share. | 3,196 |
| 3/5/2026 | COLLIS STEVEN HOWARD | Director | Purchase at price 289.84 per share. | 3,000 |
| 8/19/2025 | DEVORE SUSAN D | Director | Purchase at price 312.15 per share. | 1,200 |
| 7/18/2025 | BOUDREAUX GAIL A KOZIARA | Chief Executive Officer | Purchase at price 286.07 - 287.96 per share. | 8,500 |
A. The current target price for Elevance Health, Inc. is $451.38, which implies a 14.0% upside from the current price of $396.09. This is based on the consensus of 21 Wall Street analysts.
A. Currently, there are 2 Strong Buy, 12 Buy, 8 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.
A. Over the past 6 months, there have been 5 insider buys and 5 insider sells. Insider selling is more prominent recently.
Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.
Read full disclaimer →